Cell 'Under Review': What Each Status Means and Realistic Timelines

Before your paper reaches "Under Review," Cell editors conduct a rigorous desk review. Papers that survive this stage have demonstrated:

• A complete mechanistic story. Not an isolated finding, but a narrative arc: observation → mechanism → validation → significance
• Multi-system or multi-approach validation. In vitro, in vivo, and ideally human data. Different experimental modalities (biochemistry, genetics, imaging, functional assays)
• Conceptual advance. Does this change understanding of a biological process, or just add data points?

• Clear biological significance. Why does this mechanism matter? What could change because of this finding?

If you cleared the desk, the editor believes your work meets Cell's fundamental bar. That's a strong signal.

Cell typically assigns 2-3 expert reviewers. The process is rigorous:

Reviewer selection. Cell's editorial team chooses reviewers with direct expertise in your specific area, ensuring thorough evaluation of both data and claims.

What reviewers assess:

• Are the mechanistic claims supported by the experimental evidence?
• Do multiple independent lines of evidence converge on the same conclusion?
• Are there alternative explanations the authors haven't adequately addressed?
• Is the experimental system biologically relevant (not just convenient)?
• Would a typically rigorous scientist in this field accept these conclusions?
• Is the writing clear? Do figures effectively communicate the data?

Cell reviewers tend to ask for additional experiments more often than reviewers at other journals. This is normal. The expectation is that your story should be complete and well-supported before publication.

Cell Press has a unique editorial stage that other journals don't commonly use. If you receive a "revise before review" letter, the editor is saying: "This is promising, but we need you to address specific concerns before we send it to reviewers."

This is a positive signal. The editor chose to invest time in your paper rather than desk reject it. They're essentially saying: "You're close to review-quality. Here are the gaps."

Common revision-before-review requests:

• Additional validation experiments (usually 2-4 specific experiments)
• Clearer mechanistic explanation
• Better controls or more rigorous statistical analysis
• Human data to complement animal models
• Reorganization to improve clarity

Respond quickly (usually 2-4 weeks is expected) and address every point explicitly. If you satisfy the editor's concerns, you'll enter peer review in a strong position.

Accept without revision. Extremely rare. Maybe 5% of Cell papers are accepted without any requested changes. If this happens, you've achieved something remarkable.

Minor revision. The paper is accepted pending small changes. Usually 2-4 weeks to revise. This is a strong positive outcome.

Major revision. The most common positive outcome. Reviewers and editors want specific changes, additional analyses, or clarifications. Cell major revisions typically require 4-12 weeks of work. Address every reviewer comment point-by-point.

Reject. Even papers in review can be rejected. Maybe 40-50% of papers that reach peer review at Cell are ultimately rejected. The editor's letter will explain what fell short.

If you get revision requests:

1. Document every reviewer comment. Create a spreadsheet or response document with each comment and your response.
2. Don't skip anything. Address every point, even if you disagree. If you can't do what's asked, explain why clearly.
3. Highlight new data. If you generated new figures or experiments, make it obvious what's new vs. what was in the original.
4. Be transparent. If a reviewer asks for something and you can't provide it, say so. Don't omit limitations.
5. Stick to the timeline. Cell gives revision deadlines. Respect them. If you need an extension, ask early.
6. Respond with evidence. If a reviewer questions your interpretation, provide additional data to support your position.

Cell's rejection rate after review is significant. But if your paper was good enough for Cell review, it's competitive at other top-tier journals:

Cell Press has a transfer system. When Cell rejects a paper, the editor may suggest Molecular Cell or another family journal. Take this suggestion seriously.

Cell's timeline depends heavily on whether you get revision-before-review and how much additional work reviewers request.

• 0-2 weeks under review: Too early. Don't contact the journal.

• 2-4 weeks: Still normal. Be patient.

• 4-6 weeks: Approaching upper end. A brief, polite inquiry is reasonable.

• 6+ weeks: Follow up if you haven't heard back. Send a concise inquiry to the editor.

Keep messages short: "I'm writing to check on the status of manuscript CELL-XXXX. Any update on expected timeline would be helpful."

• Cell journal guide
• Cell submission guide
• Cell acceptance rate
• Cell Press family journals
• Nature vs Cell - head-to-head comparison
• Acceptance rates across 50+ journals
• Review timelines compared

In our pre-submission review work with manuscripts targeting Cell, three failure patterns generate the most consistent desk rejections and major revision requests. We find these across manuscripts we've reviewed through our Cell submission readiness check.

The discovery paper that stops at "what" without explaining "how." Cell's editorial standard is mechanistic depth: the paper must explain not just what happens but why the molecular mechanism produces the biological outcome. We observe that papers characterizing a new interaction or new gene function without demonstrating the downstream mechanistic consequence generate reviewer requests for mechanistic completeness in the majority of cases. Including a mechanistic model supported by epistasis experiments, rescue experiments, or biochemical reconstitution substantially reduces this revision category.

The single-model-organism finding framed as a general biological principle. Cell reviews papers claiming broad significance in fundamental biology, and reviewers evaluate whether the cross-system validation supports that claim. We find that papers demonstrating a mechanism in one cell line or one model organism that claim to establish a general principle generate reviewer requests for validation in an independent system in over half of cases. SciRev community data for Cell identifies cross-species or cross-context validation as a recurring revision request on mechanistic papers. Including a second biological system at initial submission, even if the data is less complete, preempts this predictable request.

The pathway component paper where novelty depends on what reviewers already know. Cell editors and reviewers are experts in the field. We observe that papers adding a new protein to a well-characterized pathway, without establishing that this addition changes how the pathway is understood mechanistically, generate desk rejections citing insufficient novelty for the flagship. The fix is to reframe the paper around what the new component reveals about the pathway mechanism that was not understood before, rather than framing the finding as "we identified a new regulator of X."